<p>Baseline, 1-year, and 2-year follow-up data on (A) MMSE indicating global cognition, (B) ADNI-Mem indicating memory function and (C) ADNI-EF indicating executive function are plotted, with means and standard errors. AD, Alzheimer’s disease; BI, Both impaired; HA, Hippocampal atrophy only; CA, Cortical atrophy only; BS, Both spared; MMSE; Mini-mental state examination; ADNI-Mem, composite score of memory function; ADNI-EF, composite score of executive function.</p
To determine the size of the impairment across different cognitive domains in preclinical Alzheimer’...
Abstract. We investigated the earliest neuropsychological changes in Alzheimer’s disease (AD) by com...
OBJECTIVE: The aim of the present study was to evaluate the temporal change of the cognitive decline...
Mild cognitive impairment (MCI) has emerged as a classification for a prodromal phase of cognitive d...
Objective: Mild cognitive impairment (MCI) has emerged as a classification for a prodromal phase of ...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease marked by deficits in episodic m...
Introduction: An explanation for the worldwide struggle to find a cure for Alzheimer’s disease (AD) ...
Objective: We studied the biomarker signatures and prognoses of 3 different subtle cognitive impairm...
ObjectiveWe studied the biomarker signatures and prognoses of 3 different subtle cognitive impairmen...
ObjectiveWe previously identified 4 empirically derived mild cognitive impairment (MCI) subtypes via...
and neuroimaging studies converge to indicate that psy-chological functions other than episodic memo...
Background: We sought to identify optimal approaches by calibrating longitudinal cognitive performan...
<p>Z<sub>mem</sub>: Z score of memory; Z<sub>exe</sub>: Z score of executive function; Z<sub>visuo</...
<div><p>Objective</p><p>To compare the rate of cognitive and functional decline in dysexecutive, typ...
Age-related changes in cognition are partially mediated by the presence of neuropathology and neurod...
To determine the size of the impairment across different cognitive domains in preclinical Alzheimer’...
Abstract. We investigated the earliest neuropsychological changes in Alzheimer’s disease (AD) by com...
OBJECTIVE: The aim of the present study was to evaluate the temporal change of the cognitive decline...
Mild cognitive impairment (MCI) has emerged as a classification for a prodromal phase of cognitive d...
Objective: Mild cognitive impairment (MCI) has emerged as a classification for a prodromal phase of ...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease marked by deficits in episodic m...
Introduction: An explanation for the worldwide struggle to find a cure for Alzheimer’s disease (AD) ...
Objective: We studied the biomarker signatures and prognoses of 3 different subtle cognitive impairm...
ObjectiveWe studied the biomarker signatures and prognoses of 3 different subtle cognitive impairmen...
ObjectiveWe previously identified 4 empirically derived mild cognitive impairment (MCI) subtypes via...
and neuroimaging studies converge to indicate that psy-chological functions other than episodic memo...
Background: We sought to identify optimal approaches by calibrating longitudinal cognitive performan...
<p>Z<sub>mem</sub>: Z score of memory; Z<sub>exe</sub>: Z score of executive function; Z<sub>visuo</...
<div><p>Objective</p><p>To compare the rate of cognitive and functional decline in dysexecutive, typ...
Age-related changes in cognition are partially mediated by the presence of neuropathology and neurod...
To determine the size of the impairment across different cognitive domains in preclinical Alzheimer’...
Abstract. We investigated the earliest neuropsychological changes in Alzheimer’s disease (AD) by com...
OBJECTIVE: The aim of the present study was to evaluate the temporal change of the cognitive decline...